Strategic Acquisitions Valeant Pharmaceuticals has a track record of strategic acquisitions, such as acquiring Bausch + Lomb and Sprout Pharmaceuticals. Business development professionals can explore partnerships or acquisition opportunities within the pharmaceutical sector.

Market Expansion With recent acquisitions like Acnefree and product launches like Flibanserin, Valeant is actively expanding its market presence. Sales development representatives can target these newly acquired product lines for potential sales opportunities.

Financial Health Despite past issues, Valeant's revenue stands at over $1 billion, indicating financial stability. Sales teams can leverage this information to negotiate deals confidently with Valeant as a financially robust partner.

Competitive Landscape Valeant's key competitors, such as Sunovion Pharmaceuticals and Pfizer, operate in a similar revenue range, presenting potential sales opportunities for differentiation. Sales professionals can highlight Valeant's unique offerings to stand out in a competitive market.

Technology Adoption Valeant utilizes a technology stack including DNN, jQuery, and Google Analytics, showcasing a tech-forward approach. Business development professionals can leverage this tech-savvy image to appeal to Valeant's innovation-driven culture for collaboration.